These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28603270)

  • 1. Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).
    Bandurska E; Damps-Konstańska I; Popowski P; Jędrzejczyk T; Janowiak P; Świętnicka K; Zarzeczna-Baran M; Jassem E
    Med Sci Monit; 2017 Jun; 23():2850-2862. PubMed ID: 28603270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).
    Bandurska E; Damps-Konstańska I; Popowski P; Jędrzejczyk T; Janowiak P; Świętnicka K; Zarzeczna-Baran M; Jassem E
    Med Sci Monit; 2019 Apr; 25():2879-2885. PubMed ID: 31002103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS; Shukla A; Müllerova H
    Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD.
    Jain VV; Allison R; Beck SJ; Jain R; Mills PK; McCurley JW; Van Gundy KP; Peterson MW
    Respir Med; 2014 Dec; 108(12):1794-800. PubMed ID: 25294691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
    Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
    Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an integrated care programme on re-hospitalization of patients with chronic obstructive pulmonary disease.
    Moullec G; Lavoie KL; Rabhi K; Julien M; Favreau H; Labrecque M
    Respirology; 2012 May; 17(4):707-14. PubMed ID: 22404478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of Treatment of Chronic Obstructive Pulmonary Disease.
    Milewska A; Rysiak E; Zareba I; Holownia A; Mroz RM
    Adv Exp Med Biol; 2016; 885():67-75. PubMed ID: 26801145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial.
    Hernández C; Alonso A; Garcia-Aymerich J; Serra I; Marti D; Rodriguez-Roisin R; Narsavage G; Carmen Gomez M; Roca J;
    NPJ Prim Care Respir Med; 2015 Apr; 25():15022. PubMed ID: 25856791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.